{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:39:35Z","timestamp":1791549575518,"version":"4.3.4"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z241100009024057"],"award-info":[{"award-number":["Z241100009024057"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canlet.2025.217792","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T02:46:54Z","timestamp":1747882014000},"page":"217792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Harnessing exosomes: From tumor immune escape to therapeutic innovation in gastric cancer immunotherapy"],"prefix":"10.1016","volume":"626","author":[{"given":"Zhao","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4030-8600","authenticated-orcid":false,"given":"Yanshuo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217792_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2025.217792_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41575-022-00726-3","article-title":"Updated epidemiology of gastrointestinal cancers in East Asia","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2025.217792_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40364-024-00720-8","article-title":"The burden of Gastric Cancer and possible risk factors from 1990 to 2021, and projections until 2035: findings from the Global Burden of Disease Study 2021","volume":"13","author":"Qin","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2025.217792_bib5","doi-asserted-by":"crossref","unstructured":"J. Lin, Screening of Gastric Cancer: Who, when, and How, vol. 12 (n.d.).","DOI":"10.1016\/j.cgh.2013.09.064"},{"key":"10.1016\/j.canlet.2025.217792_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2025.217792_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","article-title":"Current developments in gastric cancer: from molecular profiling to treatment strategy","volume":"20","author":"Alsina","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2025.217792_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"Nivolumab plus chemotherapy versus chemotherapy as first-line treatment for advanced gastric cancer\/gastroesophageal junction cancer\/oesophageal adenocarcinoma (CheckMate 649): a multicentre, randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.canlet.2025.217792_bib10","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","article-title":"KEYNOTE-811 Investigators, Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial","volume":"402","author":"Janjigian","year":"2023","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.canlet.2025.217792_bib11","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217792_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217792_bib13","article-title":"PD-1 inhibitors plus oxaliplatin or cisplatin-based chemotherapy in first-line treatments for advanced gastric cancer: a network meta-analysis","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib14","article-title":"Recent progress and future perspectives of immunotherapy in advanced gastric cancer","volume":"13","author":"Jin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217792_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-023-01898-5","article-title":"Extracellular vesicles remodel tumor environment for cancer immunotherapy","volume":"22","author":"Yue","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib17","article-title":"The biology and function of extracellular vesicles in immune response and immunity","volume":"57","author":"R","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2025.217792_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCRESAHA.123.323054","article-title":"The discovery of extracellular vesicles and their emergence as a next-generation therapy","volume":"135","author":"Rai","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.canlet.2025.217792_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology , function , and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217792_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","article-title":"Exosome-based liquid biopsies in cancer: opportunities and challenges","volume":"32","author":"Yu","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib21","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2217\/fon-2017-0343","article-title":"The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy","volume":"13","author":"Whiteside","year":"2017","journal-title":"Future Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib22","first-page":"1","article-title":"Extracellular vesicles mediated gastric cancer immune response: tumor cell death or immune escape?","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217792_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-019-1074-3","article-title":"The role of exosomal PD-L1 in tumor progression and immunotherapy","volume":"18","author":"Xie","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","article-title":"Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy","volume":"17","author":"Lu","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-023-01382-y","article-title":"Engineered exosomes from different sources for cancer-targeted therapy","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.217792_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2022.11.053","article-title":"Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies","volume":"353","author":"Li","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2025.217792_bib27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.cellbio.23.090506.123319","article-title":"Biogenesis and function of multivesicular bodies","volume":"23","author":"Piper","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217792_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: from biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2025.217792_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2017","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.canlet.2025.217792_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15071992","article-title":"From exosome biogenesis to absorption: key takeaways for cancer research","volume":"15","author":"Lau","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2025.217792_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00163","article-title":"Endosome-to-TGN trafficking: organelle-vesicle and organelle-organelle interactions","volume":"8","author":"Tu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217792_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejcb.2017.02.005","article-title":"Traffic from the endosome towards trans-Golgi network","volume":"96","author":"Saimani","year":"2017","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217792_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcdb.2017.08.020","article-title":"ESCRT-dependent cargo sorting at multivesicular endosomes","volume":"74","author":"Frankel","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217792_bib34","article-title":"RNA and protein delivery by cell\u2010secreted and bioengineered extracellular vesicles","volume":"11","author":"Wang","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.canlet.2025.217792_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217792_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217792_bib37","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cmet.2021.08.006","article-title":"Exosomes as mediators of intercellular crosstalk in metabolism","volume":"33","author":"Isaac","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2025.217792_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3892\/ijo.2024.5706","article-title":"Exosomal integrins in tumor progression, treatment and clinical prediction (Review)","volume":"65","author":"Shen","year":"2024","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib39","first-page":"1","article-title":"Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2025.217792_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12929-023-00964-w","article-title":"Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments","volume":"30","author":"Nail","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.canlet.2025.217792_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2023.100032","article-title":"Exosome as drug delivery system: current advancements","volume":"3","author":"Sharma","year":"2024","journal-title":"Extracell. Vesicle"},{"key":"10.1016\/j.canlet.2025.217792_bib42","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3390\/nano11061481","article-title":"Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives","volume":"11","author":"Butreddy","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.canlet.2025.217792_bib43","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3390\/cancers16122211","article-title":"Dendritic cells in shaping anti-tumor T cell response","volume":"16","author":"Mazzoccoli","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2025.217792_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40164-023-00459-2","article-title":"Deciphering tumor-infiltrating dendritic cells in the single-cell era","volume":"12","author":"Huang","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib45","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2017.02.23","article-title":"Dendritic cell-derived exosomes for cancer immunotherapy: hope and challenges","volume":"5","author":"Tian","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.canlet.2025.217792_bib46","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3390\/microorganisms8111776","article-title":"Exosomes of epstein-barr virus-associated gastric carcinoma suppress dendritic cell maturation","volume":"8","author":"Hinata","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.canlet.2025.217792_bib47","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/02656736.2011.564598","article-title":"Induction of a tumour-specific CTL response by exosomes isolated from heat-treated malignant ascites of gastric cancer patients","volume":"27","author":"Zhong","year":"2011","journal-title":"Int. J. Hyperth. Off. J. Eur. Soc. Hyperthermic Oncol. North Am. Hyperth. Group"},{"key":"10.1016\/j.canlet.2025.217792_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3892\/ol.2015.3155","article-title":"Effect of hyperthermic CO2-treated dendritic cell-derived exosomes on the human gastric cancer AGS cell line","volume":"10","author":"Wang","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2025.217792_bib49","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/ijc.34921","article-title":"Shaping the immune-suppressive microenvironment on tumor-associated myeloid cells through tumor-derived exosomes","volume":"154","author":"Wang","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.28549","article-title":"Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro","volume":"64","author":"Rao","year":"2016","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.canlet.2025.217792_bib51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12943-021-01376-w","article-title":"The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells","volume":"20","author":"Hosseini","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib52","doi-asserted-by":"crossref","first-page":"29877","DOI":"10.18632\/oncotarget.4924","article-title":"Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p","volume":"6","author":"Ding","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217792_bib53","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s41467-024-45358-0","article-title":"Adjuvant dendritic cell therapy in stage IIIB\/C melanoma: the MIND-DC randomized phase III trial","volume":"15","author":"Bol","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217792_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.2015113","article-title":"Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients","volume":"11","author":"Bloemendal","year":"2022","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2025.217792_bib55","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1158\/1078-0432.CCR-23-0235","article-title":"Randomized phase II trial of dendritic cell\/myeloma fusion vaccine with lenalidomide maintenance after upfront autologous hematopoietic cell transplantation for multiple myeloma: bmt ctn 1401","volume":"29","author":"Chung","year":"2023","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217792_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","article-title":"Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411306","article-title":"Engineered human dendritic cell exosomes as effective delivery system for immune modulation","volume":"24","author":"Elsayed","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217792_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","article-title":"Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion","volume":"13","author":"Lu","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4251\/wjgo.v13.i1.1","article-title":"Myeloid-derived suppressor cells in gastrointestinal cancers: a systemic review","volume":"13","author":"Farshidpour","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib61","article-title":"Roles of the exosomes derived from myeloid-derived suppressor cells in tumor immunity and cancer progression","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib62","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.2147\/CMAR.S198886","article-title":"Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer","volume":"11","author":"Ren","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.canlet.2025.217792_bib63","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1186\/s12967-024-05611-y","article-title":"The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2025.217792_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104258","article-title":"Molecular cargo in myeloid-derived suppressor cells and their exosomes","volume":"359","author":"Fenselau","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12974-024-03222-4","article-title":"Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy","volume":"21","author":"Wen","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.canlet.2025.217792_bib66","article-title":"Neutrophils in cancer: dual roles through intercellular interactions","volume":"43","author":"X","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217792_bib67","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02004-z","article-title":"Neutrophils in Cancer immunotherapy: friends or foes?","volume":"23","author":"Huang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib69","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00018-024-05484-w","article-title":"Neutrophil-centric analysis of gastric cancer: prognostic modeling and molecular insights","volume":"81","author":"Tang","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2025.217792_bib70","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-018-0898-6","article-title":"Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib71","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1086\/431992","article-title":"The role of toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis","volume":"41","author":"Sabroe","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.canlet.2025.217792_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/srep41623","article-title":"TLR-exosomes exhibit distinct kinetics and effector function","volume":"7","author":"Srinivasan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217792_bib73","article-title":"Extracellular vesicles from gastric cancer cells induce PD-L1 expression on neutrophils to suppress T-cell immunity","volume":"10","author":"Y","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib74","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12943-024-02116-6","article-title":"Exosomal miR-4745-5p\/3911 from N2-polarized tumor-associated neutrophils promotes gastric cancer metastasis by regulating SLIT2","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib75","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib76","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1042\/CS20220531","article-title":"M1\/M2 macrophages and their overlaps \u2013 myth or reality?","volume":"137","author":"Strizova","year":"2023","journal-title":"Clin. Sci. Lond. Engl."},{"key":"10.1016\/j.canlet.2025.217792_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.763334","article-title":"Polarized macrophages in periodontitis: characteristics, function, and molecular signaling","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib78","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102015","article-title":"The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target","volume":"86","author":"Gambardella","year":"2020","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2025.217792_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1327281","article-title":"Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment","volume":"15","author":"Qiu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1017745","article-title":"MIR4435-2HG in exosomes promotes gastric carcinogenesis by inducing M2 polarization in macrophages","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41389-018-0049-3","article-title":"Tumor-derived exosomes induce PD1+ macrophage population in human gastric cancer that promotes disease progression","volume":"7","author":"Wang","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2025.217792_bib83","article-title":"Exosomal miRNA-16-5p derived from M1 macrophages enhances T cell-dependent immune response by regulating PD-L1 in gastric cancer","volume":"8","author":"Z","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217792_bib84","article-title":"Tumor-associated macrophage-derived exosomes promote the progression of gastric cancer by regulating the P38MAPK signaling pathway and the immune checkpoint PD-L1","author":"Wang","year":"2021","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.canlet.2025.217792_bib85","article-title":"M2 tumor-associated macrophages-derived exosomal MALAT1 promotes glycolysis and gastric cancer progression","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. Weinh. Baden-Wurtt. Ger."},{"key":"10.1016\/j.canlet.2025.217792_bib86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib87","first-page":"8389","article-title":"Tumor cells induced-M2 macrophage favors accumulation of Treg in nasopharyngeal carcinoma","volume":"10","author":"Wang","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2025.217792_bib88","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.ymthe.2020.06.003","article-title":"Exosomes: a potential therapeutic tool targeting communications between tumor cells and macrophages","volume":"28","author":"Guo","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2025.217792_bib89","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12935-020-1163-9","article-title":"M2 bone marrow-derived macrophage-derived exosomes shuffle microRNA-21 to accelerate immune escape of glioma by modulating PEG3","volume":"20","author":"Yang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2025.217792_bib90","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2022.09.022","article-title":"Human natural killer cells: form, function, and development","volume":"151","author":"Mace","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib91","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217792_bib92","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/2159-8290.CD-20-0655","article-title":"Tumor-infiltrating natural killer cells","volume":"11","author":"C\u00f3zar","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.217792_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.849938","article-title":"Extracellular vesicles and transforming growth factor \u03b2 signaling in cancer","volume":"10","author":"Rodrigues-Junior","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217792_bib94","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1007\/s10620-024-08536-0","article-title":"Regulation of the PD-1\/PD-L1 Axis and NK cell dysfunction by exosomal miR-552-5p in gastric cancer","volume":"69","author":"Tang","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.canlet.2025.217792_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1230","article-title":"NKG2D and MICA\/B shedding: a \u2018tag game\u2019 between NK cells and malignant cells","volume":"9","author":"Xing","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib96","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib97","article-title":"Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions","volume":"10","author":"Liu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217792_bib98","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12943-024-02045-4","article-title":"Natural killer cell-derived exosome-based cancer therapy: from biological roles to clinical significance and implications","volume":"23","author":"Si","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib99","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/pharmaceutics16070939","article-title":"Natural killer-based therapy: a prospective thought for cancer treatment related to diversified drug delivery pathways","volume":"16","author":"Zang","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2025.217792_bib100","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1294368","article-title":"Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells","volume":"6","author":"Jong","year":"2017","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.canlet.2025.217792_bib101","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1084\/jem.20181454","article-title":"NK cells switch from granzyme B to death receptor\u2013mediated cytotoxicity during serial killing","volume":"216","author":"Prager","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2025.217792_bib102","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1158\/0008-5472.CAN-16-0431","article-title":"The emerging role of B cells in tumor immunity","volume":"76","author":"Tsou","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217792_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.881427","article-title":"Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity","volume":"13","author":"Qin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1519034","article-title":"Role of tertiary lymphoid structures and B cells in clinical immunotherapy of gastric cancer","volume":"15","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib105","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/1078-0432.CCR-21-1130","article-title":"B cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy?","volume":"28","author":"Lauss","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217792_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49581-4","article-title":"Increased regulatory B cells are involved in immune evasion in patients with gastric cancer","volume":"9","author":"Murakami","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217792_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107581","article-title":"Role of regulatory B cells in gastric cancer: latest evidence and therapeutics strategies","volume":"96","author":"Jing","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.canlet.2025.217792_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188760","article-title":"Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes","volume":"14","author":"Xiong","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib109","article-title":"Plasma cells shape the mesenchymal identity of ovarian cancers through transfer of exosome-derived microRNAs","volume":"7","author":"Yang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2025.217792_bib110","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-018-0451-6","article-title":"Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion","volume":"6","author":"Ye","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib111","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","article-title":"Principles and therapeutic applications of adaptive immunity","volume":"187","author":"Chi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217792_bib112","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217792_bib113","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-019-1074-3","article-title":"The role of exosomal PD-L1 in tumor progression and immunotherapy","volume":"18","author":"Xie","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib114","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-022-01557-1","article-title":"LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer","volume":"21","author":"Shen","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108414","article-title":"Helicobacter pylori CagA promotes immune evasion of gastric cancer by upregulating PD-L1 level in exosomes","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2025.217792_bib116","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1158\/0008-5472.CAN-06-3456","article-title":"Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2","volume":"67","author":"Clayton","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217792_bib117","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bcmd.2005.07.001","article-title":"Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis","volume":"35","author":"Abusamra","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.canlet.2025.217792_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/srep20254","article-title":"Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets","volume":"6","author":"Muller","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217792_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1181499","article-title":"Regulation of T cell differentiation and function by long noncoding RNAs in homeostasis and cancer","volume":"14","author":"Erber","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00262-021-02991-8","article-title":"Gastric cancer-derived exosomal miR-135b-5p impairs the function of V\u03b39V\u03b42 T cells by targeting specificity protein 1","volume":"71","author":"Li","year":"2022","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"10.1016\/j.canlet.2025.217792_bib121","article-title":"T cell-derived exosomes in tumor immune modulation and immunotherapy","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib122","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/eji.201646786","article-title":"Help to go: T cells transfer CD40L to antigen-presenting B cells","volume":"47","author":"Dustin","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib123","article-title":"Roles of regulatory T cell-derived extracellular vesicles in human diseases","volume":"23","author":"Lin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217792_bib124","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41598-018-24531-8","article-title":"Regulatory T cell-derived extracellular vesicles modify dendritic cell function","volume":"8","author":"Tung","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217792_bib125","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41419-022-05320-8","article-title":"The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217792_bib126","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6270784","article-title":"Role of cancer-associated fibroblast in gastric cancer progression and resistance to treatments","volume":"2019","author":"Ham","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib127","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2025.217792_bib129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cas.15609","article-title":"The heterogeneity of cancer-associated fibroblast subpopulations: their origins, biomarkers, and roles in the tumor microenvironment","volume":"114","author":"Yamamoto","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.217792_bib130","first-page":"2590","article-title":"Cancer-associated fibroblast-released extracellular vesicles carrying miR-199a-5p induces the progression of gastric cancer through regulation of FKBP5-mediated AKT1\/mTORC1 signaling pathway, Cell Cycle Georget","volume":"21","author":"Wang","year":"2022","journal-title":"Tex"},{"key":"10.1016\/j.canlet.2025.217792_bib131","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.7150\/jca.47817","article-title":"Exosomal miR-10b-5p mediates cell communication of gastric cancer cells and fibroblasts and facilitates cell proliferation","volume":"12","author":"Yan","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib132","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s10020-023-00665-y","article-title":"Cancer-associated fibroblasts and its derived exosomes: a new perspective for reshaping the tumor microenvironment","volume":"29","author":"Peng","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.canlet.2025.217792_bib133","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","article-title":"Cancer associated-fibroblast-derived exosomes in cancer progression","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-024-02146-5","article-title":"The role of cancer-associated fibroblasts and exosomal miRNAs-mediated intercellular communication in the tumor microenvironment and the biology of carcinogenesis: a systematic review","volume":"10","author":"Nedaeinia","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2025.217792_bib135","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1158\/1541-7786.MCR-17-0784","article-title":"Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through TGF\u03b2 signaling","volume":"16","author":"Ringuette Goulet","year":"2018","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.canlet.2025.217792_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.111983","article-title":"Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment","volume":"391","author":"Yang","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2025.217792_bib137","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib138","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12951-024-02452-1","article-title":"An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments","volume":"22","author":"Xue","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2025.217792_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103628","article-title":"New advances in exosome-based targeted drug delivery systems","volume":"172","author":"Ferreira","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2025.217792_bib140","article-title":"Exosomes as drug carriers in anti-cancer therapy","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217792_bib141","article-title":"Exosomes: from basic research to clinical diagnostic and therapeutic applications in cancer","author":"Araujo-Abad","year":"2024","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib142","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2020.05.004","article-title":"Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs","volume":"486","author":"Chinnappan","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217792_bib143","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1245\/s10434-019-07431-7","article-title":"Exosomal PD-L1 retains immunosuppressive activity and is associated with gastric cancer prognosis","volume":"26","author":"Fan","year":"2019","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib144","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217792_bib145","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00262-022-03355-6","article-title":"A nanotherapeutic system for gastric cancer suppression by synergistic chemotherapy and immunotherapy based on iPSCs and DCs exosomes","volume":"72","author":"Li","year":"2023","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"10.1016\/j.canlet.2025.217792_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117013","article-title":"Tumor-associated macrophage-derived exosomal miR-513b-5p is a target of jianpi yangzheng decoction for inhibiting gastric cancer","volume":"318","author":"Zhang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.canlet.2025.217792_bib147","article-title":"Melatonin enhances anti-tumor immunity by targeting macrophages PD-L1 via exosomes derived from gastric cancer cells","volume":"568\u2013569","author":"Wang","year":"2023","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.canlet.2025.217792_bib148","article-title":"m6 A reader YTHDF1-targeting engineered small extracellular vesicles for gastric cancer therapy via epigenetic and immune regulation","volume":"35","author":"You","year":"2023","journal-title":"Adv. Mater. Deerfield Beach Fla"},{"key":"10.1016\/j.canlet.2025.217792_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116182","article-title":"Identification of the exosomal PD-L1 inhibitor to promote the PD-1 targeting therapy of gastric cancer","volume":"268","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2025.217792_bib150","series-title":"Patients with Advanced Hepatocellular Carcinoma (HCC) and Patients with Liver Metastases from Either Primary Gastric Cancer or Colorectal Cancer (CRC)","article-title":"Phase 1 study of macrophage reprogramming agent, exoASO-STAT6 (CDK-004)","author":"BioSciences","year":"2023"},{"key":"10.1016\/j.canlet.2025.217792_bib151","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-024-01578-x","article-title":"Recent developments in immunotherapy for gastrointestinal tract cancers","volume":"17","author":"Chong","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib152","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.3390\/ijms25126471","article-title":"Immunotherapy based on immune checkpoint molecules and immune checkpoint inhibitors in gastric cancer-narrative review","volume":"25","author":"Poniewierska-Baran","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217792_bib153","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217792_bib154","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib155","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1172\/JCI80011","article-title":"Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future","volume":"125","author":"Chen","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.217792_bib156","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.trecan.2020.03.002","article-title":"Exosomal PD-L1: roles in tumor progression and immunotherapy","volume":"6","author":"Morrissey","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2025.217792_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116182","article-title":"Identification of the exosomal PD-L1 inhibitor to promote the PD-1 targeting therapy of gastric cancer","volume":"268","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2025.217792_bib158","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217792_bib159","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.21873\/anticanres.16637","article-title":"Melatonin inhibits gastric cancer cell proliferation by suppressing exosome miR-27b-3p expression","volume":"43","author":"Zhang","year":"2023","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2025.217792_bib160","article-title":"Jianpi Yangzheng Xiaozheng decoction alleviates gastric cancer progression via suppressing exosomal PD-L1","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217792_bib161","article-title":"Delivery of extracellular vesicles loaded with immune checkpoint inhibitors for immunotherapeutic management of glioma","volume":"28","author":"Lin","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.canlet.2025.217792_bib162","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.actbio.2020.08.008","article-title":"Anti-CTLA-4 antibody-functionalized dendritic cell-derived exosomes targeting tumor-draining lymph nodes for effective induction of antitumor T-cell responses","volume":"115","author":"Phung","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.canlet.2025.217792_bib163","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.3390\/cancers14174167","article-title":"Extracellular vesicle-derived protein file from peripheral blood predicts immune-related adverse events in gastric cancer patients receiving immunotherapy","volume":"14","author":"Jiang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2025.217792_bib164","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12209","article-title":"Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer","volume":"11","author":"Zhang","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.canlet.2025.217792_bib165","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.21037\/tcr-24-2151","article-title":"The efficacy of plasma exosomal miRNAs as predictive biomarkers for PD-1 blockade plus chemotherapy in gastric cancer","volume":"13","author":"Hua","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217792_bib166","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70569","article-title":"Diagnostic and prognostic significance of exosomes and their components in patients with cancers","volume":"14","author":"Moni","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2025.217792_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216989","article-title":"Exosome-based anticancer vaccines: from Bench to bedside","volume":"595","author":"Zhao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217792_bib168","article-title":"Exosome-based vaccines: pioneering new frontiers in combating infectious diseases and cancer","author":"Wang","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.canlet.2025.217792_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.711565","article-title":"Exosome-based vaccines: history, current state, and clinical trials","volume":"12","author":"Santos","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib170","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.3390\/cancers13153667","article-title":"DC-derived exosomes for cancer immunotherapy","volume":"13","author":"Yao","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2025.217792_bib171","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13046-020-01781-x","article-title":"Dexosomes as a cell-free vaccine for cancer immunotherapy","volume":"39","author":"Nikfarjam","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217792_bib172","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.semcancer.2023.02.002","article-title":"Extracellular vesicles as next generation immunotherapeutics","volume":"90","author":"Greening","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217792_bib173","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1021\/acsnano.4c18056","article-title":"EXOTLR1\/2-STING: a dual-mechanism stimulator of Interferon genes activator for cancer immunotherapy","volume":"19","author":"Wang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2025.217792_bib174","first-page":"491","article-title":"Engineered tumor cell-derived vaccines against cancer: the art of combating poison with poison","volume":"22","author":"Zhang","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.canlet.2025.217792_bib175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-3-9","article-title":"A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer","volume":"3","author":"Morse","year":"2005","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2025.217792_bib176","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/s41467-023-42402-3","article-title":"Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer","volume":"14","author":"Chiang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217792_bib177","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/febs.15558","article-title":"Exosomes as mediators of immune regulation and immunotherapy in cancer","volume":"288","author":"Kugeratski","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2025.217792_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1093607","article-title":"Exosomes as smart drug delivery vehicles for cancer immunotherapy","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib179","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","volume":"3","author":"Th\u00e9ry","year":"2006","journal-title":"Curr. Protoc. Cell Biol. Chapter"},{"key":"10.1016\/j.canlet.2025.217792_bib180","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217792_bib181","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.canlet.2025.217792_bib182","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8545347","article-title":"Isolation of extracellular vesicles: general methodologies and latest trends","volume":"2018","author":"Konoshenko","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.canlet.2025.217792_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.fmre.2023.11.024","article-title":"Engineering exosomes and exosome-like nanovesicles for improving tissue targeting and retention","author":"Li","year":"2024","journal-title":"Fundam. Res."},{"key":"10.1016\/j.canlet.2025.217792_bib184","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1111\/cas.15497","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"113","author":"Nagasaki","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.217792_bib185","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11912-023-01380-x","article-title":"CAR-T therapies in solid tumors: opportunities and challenges","volume":"25","author":"Guzman","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217792_bib186","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn","volume":"21","author":"Albelda","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217792_bib187","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s41232-024-00358-x","article-title":"Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy","volume":"44","author":"Zhang","year":"2024","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.canlet.2025.217792_bib188","first-page":"497","article-title":"ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance, Commun","volume":"4","author":"Jang","year":"2021","journal-title":"Biol."},{"key":"10.1016\/j.canlet.2025.217792_bib189","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.imlet.2021.08.004","article-title":"TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in mice","volume":"239","author":"Yildirim","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.canlet.2025.217792_bib190","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk1098","article-title":"Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer","volume":"9","author":"Hyung","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2025.217792_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102040","article-title":"CRISPR-Cas9 delivery strategies with engineered extracellular vesicles","volume":"34","author":"Lu","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.canlet.2025.217792_bib192","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1093607","article-title":"Exosomes as smart drug delivery vehicles for cancer immunotherapy","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217792_bib193","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1594","article-title":"Advances in imaging strategies for in vivo tracking of exosomes","volume":"12","author":"Betzer","year":"2020","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2025.217792_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114974","article-title":"Towards artificial intelligence-enabled extracellular vesicle precision drug delivery","volume":"199","author":"Greenberg","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2025.217792_bib195","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/app14041639","article-title":"Extracellular vesicles and artificial intelligence: unique weapons against breast cancer","volume":"14","author":"Serretiello","year":"2024","journal-title":"Appl. Sci."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:02:15Z","timestamp":1760742135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525003593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":194,"alternative-id":["S0304383525003593"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217792","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing exosomes: From tumor immune escape to therapeutic innovation in gastric cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217792"}}